CARRIER SCREEN - LIST OF DISORDERS
|
|
- Aldous Gallagher
- 5 years ago
- Views:
Transcription
1 1 11-Beta-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 2 17-Beta-Hydroxysteroid deyhdrogenase X deficiency 3 2-Methylbutytyrglycinuria 4 21-hydroxylase deficiency 5 3-Methylcrotonyl-CoA carboxylase 1 deficiency 6 3-Methylcrotonyl-CoA carboxylase 2 deficiency 7 6-Pyruvoyl-Tetrahydropterin Synthase Deficiency 8 Aaarskog-Scottsyndrome;Mental retardation, X-linked 16 9 ABCC8-Related Hyperinsulinism 10 Abetalipoproteinemia 11 Achondrogenesis, type IB 12 Achromatopsia 3 13 Acyl-CoA dehydrogenase, medium chain deficiency of 14 Acyl-CoA dehydrogenase, short chain deficiency of 15 Adenosine Deaminase Deficiency 16 Adrenal Hyperplasia congenital due to 17-alpha-hydroxylase deficiency 17 Adrenal Hyperplasia congenital due to 21-hydroxylase deficiency 18 Adrenoleukodystrophy : X-linked 19 Alkaptonuria 20 Allan-Herndon-Dudley syndrome 21 Alpha-Mannosidosis 22 Alpha-methylacetoacetic aciduria 23 Alpha-Sarcoglycanopathy(including Limb-Girdle Muscular Dystrophy, Type 2D) 24 Alpha-Thalassemia/mental retardation syndrome 25 Alport syndrome, autosomal recessive COL4A3 related 26 Alport syndrome, autosomal recessive COL4A4 related 27 Alport syndrome, X-linked 28 Alstrom Syndrome 29 AMT-Related Glycine Encephalopathy 30 Andermann syndrome 31 Androgen insensitivity 32 Argininemia 33 Argininosuccinic aciduria 34 Aromatase deficiency 35 ARSACS 36 Arts Syndrome 37 Aspartylglucosaminuria 38 Ataxia with vitamin E deficiency 39 Ataxia-telangiectasia syndrome 40 ATP7A-Related Disordes 41 Auditory Neuropathy, autosomal recessive, 1 42 Autoimmune polyendocrinopathy syndrome, type 1 with or without reversible metaphyseal dysplasia 43 Autosomal Recessive Osteoporosis Type 1 44 Autosomal recessive polycystic kidney disease 45 Bardet-Biedl syndrome 1 46 Bardet-Biedl syndrome Bardet-Biedl syndrome Bardet-Biedl syndrome 14;Joubert syndrome 5; Meckel syndrome 4; Senior-Loken syndrome 6 49 Bardet-Biedl syndrome 2 50 Bare Lymphocyte Syndrome type II Safembryo 1/9
2 51 Bartter syndrome, type 4a 52 Beta-sarcoglycanopathy 53 Biotinidase deficiency 54 Bloom syndrome 55 Calpainopathy 56 Canavan disease, mild 57 Carbamoylphosphate synthetase I deficiency 58 Carnitine palmitoyltransferase I deficiency 59 Carnitine palmitoyltransferase II deficiency 60 Carnitine deficiency, systemic primary 61 Carnitine acylcarnitine translocase deficiency 62 Cartilage- Hair Hypoplasia 63 Cerebrotendinous xanthomatosis 64 Ceroid lipofuscinosis neuronal Ceroid lipofuscinosis neuronal 2 66 Ceroid lipofuscinosis neuronal 3 67 Ceroid lipofuscinosis neuronal 5 68 Ceroid lipofuscinosis neuronal, 6 69 Ceroid lipofuscinosis neuronal, 7 70 Ceroid lipofuscinosis neuronal 8 71 Ceroid lipofuscinosis neuronal, type 1 72 Ceroid lipofuscinosis neuronal, type 2 73 Charcot -Marie Tooth disease with deafness: X linked PRPS1 Related 74 Charcot-Marie Tooth neuropathy, X-linked 75 Charcot-Marie Tooth disease type 4B1 76 Charcot-Marie Tooth disease type 4C 77 Charcot-Marie Tooth disease type 4D 78 Charcot -Marie Tooth Neuropathy Type 4A 79 Cholestasis, benign recurrent intrahepatic, 2 80 Citrullinemia 81 Citrullinemia adult-onset type II;typw II neonatala-onset 82 Coffin-Lowry syndrome 83 Cohen Syndrome 84 Combined malonic and methylmalonic acidemia 85 Cone-rod dystrophy 3 86 Cone-rod dystrophy (Congenital Leber Amaurosis, 4) 87 Cone-rod dystrophy X-linked 88 Congenital Disorder of glycosylation Type 1a 89 Congenital Disorder of glycosylation Type 1b 90 Congenital Disorder of glycosylation Type 1c 91 Congenital Finnish Nephrosis 92 Corneal endothelial dystrophy and sensorineural deafness 93 Costeff-Optic Atrophy Syndrome 94 Crigler-Najjar syndrome, type I 95 Cystathioninouria 96 Cystic fibrosis 97 Cystic Fibrosis; Congenital bilateral absence of vas deferens 98 Cystinosis 99 Cystinosis, atypical nephropathic 100 Cystinuria Safembryo 2/9
3 101 D-Bifunctional Protein Deficiency 102 Deafness autosomal recessive Deafness autosomal recessive 18A 104 Deafness, autosomal recessive 1A 105 Deafness, autosomal recessive 1b 106 Deafness autosomal recessive Deafness autosomal recessive 4, with enlarged vestibular aqueduct 108 Delta-Sarcoglycanopathy 109 Dent disease Diabetes mellitus, neonatal, with congenital hypothyroidism 111 Diastrophic dysplasia 112 Dihydrolipoamide dehydrogenase deficiency 113 Duchene muscular dystrophy; Becker muscular dystrophy 114 Dysferlinopathy 115 Dysprothrombinemia 116 Distrophinopathies(including Duchenne/Becker muscular dystrophy) 117 Ehlers-Danlos syndrome type VI 118 Ehlers-Danlos syndrome type VIIC 119 Ellis-van Creveld syndrome 120 Emery-Dreifuss muscular dystrophy 1 X-linked 121 Emphysema due to Alpha1 Anti-Trypsin deficiency 122 Enhanced S-cone syndrome (Retinitis pigmentosa 37) 123 Epidermolysis bullosa, dystrophica, AR 124 Epidermolysis bullosa, junctional, Herlitz type; non Herlitz type 125 Epilepsy X-linked, with variable learning disabilities and behavior disorders 126 Epileptic encephalopathy, early infantile, ERCC6-Related Disorders 128 ERCC8-Related Disorders 129 Ethylmalonic encephalopathy 130 Fabry disease 131 Factor V deficiency 132 Factor V Leiden thrombophilia 133 Factor XI deficiency,autosomal dominant & recessive 134 Familial Mediterranean fever 135 Familial dysautonomia 136 Fanconi anemia 137 Fanconi anemia, complementation group A 138 Fanconi anemia, complementation group C 139 Favism 140 FKRP-Related disorders 141 FKTN-Related disorders (including Walker-Warburg syndrome) 142 Folate malabsorption,hereditary 143 Fragile X syndrome 144 Friedreich ataxia with retained reflexes 145 Fructose intolerance 146 Fumarase deficiency 147 Galactokinase deficiency with cataracts 148 Galactokinase deficiency 149 Galactose epimerase deficiency 150 Galactosemia 151 Gamma-Sarcoglycanopathy Safembryo 3/9
4 152 Gaucher disease,perinatal lethal 153 Gaucher disease types I and II 154 GJB2-Related DFNB1 Nonsyndromic hearing loss and deafness 155 GLB1-Related disorders 156 Glutamate formiminotransferase deficiency 157 Glutaric acidemia type Glutaric acidemia IIA 159 Glutaric acidemia IIB 160 Glutaric acidemia IIC 161 Glutaricaciduria, type I 162 Glycine encephalopathy 163 Glycine N-methyltransferase deficiency 164 Glycogen storage disease Ia 165 Glycogen storage disease Ib 166 Glycogen storage disease II/Pompe disease 167 Glycogen storage disease III 168 Glycogen storage disease IIIa 169 Glycogen storage disease IV 170 GM1 gangliosidosis type GM1 gangliosidosis type GM1 gangliosidosis type GNPTAB-Related disorders 174 Goldman-Favre syndrome 175 GRACILE syndrome 176 HADHA-Related disorders(including long chain 3-hydroxyacyl-CoA Deyhdrogenase deficiency) 177 HARP syndrome 178 Hartnup disorder 179 Hb beta chain -Related hemoglobinopathy(including beta thalassemia and sickle cell disease) 180 Heimler syndrome type Hemochromatosis type Hemochromatosis type 2A; HFE2 Related 183 Hemophilia A 184 Hemophilia A, factor VIII deficiency, X-linked 185 Hemophilia B 186 Hemophilia B, factor IX deficiency 187 Hereditary Fructose intolerance 188 Herlitz junctional epidermolysis bullosa LAMA3-Related 189 Herlitz junctional epidermolysis bullosa LAMB3-Related 190 Herlitz junctional epidermolysis bullosa LAMC3-Related 191 Hermansky-Pudlak syndrome Hexosaminidase A deficiency, adult type(including Tay-Sachs disease) 193 Histidinemia 194 HMG-CoA lyase deficiency 195 Holocarboxylase synthetase deficiency 196 Homocystinuria due to MTHFR deficiency 197 Homocystinuria -megaloblastic anemia, cbl E type 198 Homocystinuria B6-responsive and nonresponsive types Homocystinuria cbid type variant 1/Methylmalonic aciduria and homocystinuria, cbid type/ 199 Methylmalonic aciduria cbid type variant Homocystinuria caused by cystathionine beta-synthase deficiency 201 Hydrolethalus syndrome Safembryo 4/9
5 202 Hyper IgD syndrome; Mevalonic aciduria 203 Hypercholesterolemia familial 204 Hypercholesterolemia familial, autosomal recessive 205 Hyperinsulinemic hypoglycemia, familial Type Hypermethioninemia due to adenosine kinase deficiensy 207 Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase Hypermethioninemia persistent autosomal dominant due to methionine adenosyltransferase I/III 208 deficiency 209 Hyperoxaluria primary type I 210 Hyperoxaluria primary type II 211 Hyperoxaluria primary type III 212 Hyperoxaluria III 213 Hyperphenylalanemia, BH4-deficient A 214 Hyperphenylalanemia, BH4-deficient C 215 Hyperphenylalanemia, BH4-deficient D 216 Hyperprolinemia type II 217 Hypoidrotic Ectodermal dysplasia X-linked 218 Hypogonadotropic hypogonadism 7 without anosmia 219 Hypophospatasia infantile 220 Hypophosphatasia autosomal recessive 221 Hypothyroidism, congenital nongoitrous Hypothyroidism, congenital nongoitrous Icthyosis, congenital autosomal recessive Immunodeficiency, X-linked with hyper-igm 225 Inclusion Body myopathy Isovaleric acidemia 227 Joubert syndrome Joubert syndrome Joubert syndrome Joubert syndrome KCNJ11-Related familial hyperinsulinism 232 Krabbe Disease 233 LAMA2-Related muscular dystrophy 234 LCHAD deficiency 235 Leber congenital amaurosis Leber congenital amaurosis Leber congenital amaurosis Leber congenital amaurosis Leber congenital amaurosis Leigh syndrome due to COX deficiency 241 Leigh syndrome French-Canadian type 242 Limb-girdle muscular dystrophy type 2B 243 Limb-girdle muscular dystrophy type 2I; Muscular dystrophy dystroglycanopathy 244 Lipoamid Dehydrogenase deficiency 245 Lipoid adrenal hyperplasia 246 Lipoid congenital adrenal hyperplasia 247 Lissencephaly, X-linked 248 Lysosomal Acid lipase deficiency 249 Macular corneal dystrophy 250 Malonyl-CoA decarboxylase deficiency 251 Mannosidosis alpha- types I and II Safembryo 5/9
6 252 Maple syrup urine disease type 1A 253 Maple syrup urine disease type 1B 254 Maple syrup urine disease type MASA syndrome/crash syndrome 256 Mc Ardle disease/glycogen Storage Disease type V 257 Meckel Syndrome Medium chain Acyl-CoA dehydrogenase deficiency 259 Megalencephalic leukoencephalopathy with subcortical cysts 260 Mental retardation and microcephaly with pontine and cerebellar hypoplasia 261 Mental retardation syndrome, X-linked, siderius type 262 Mental retardation, X-linked 263 Mental retardation, X-linked 1/ Mental retardation, X-linked 12/ Mental retardation, X-linked 21/ Mental retardation, X-linked 30/ Mental retardation, X-linked Mental retardation, X-linked Mental retardation, X-linked Mental retardation, X-linked Mental retardation, X-linked Mental retardation, X-linked Mental retardation, X-linked Mental retardation, X-linked Mental retardation, X-linked syndromic Mental retardation, X-linked syndromic, Raymond type 277 Mental retardation, X-linked syndromic, Turner type 278 Mental retardation, X-linked Asperger syndrome suceptibility, X-linked 279 Mental retardation, X-linked FRAXE type 280 Mental retardation, X-linked syndromic Mental retardation, X-linked syndromic Mental retardation, X-linked syndromic Mental retardation, X-linked syndromic, Claes-Jensen type 284 Metachromatic leukodystrophy 285 Methylmalonic acidemia cbia type 286 Methylmalonic acidemia cbib type 287 Methylmalonic aciduria and homocystinuria cbic type 288 Methylmalonic aciduria and homocystinuria cbid type 289 Methylmalonic aciduria and homocystinuria cbif type 290 Methylmalonic aciduria and homocystinuria cbij type 291 Methylmalonic aciduria mut (0) type 292 Methylmalonic aciduria vitamin B12 responsive Methylmalonic aciduria vitamin B12 responsive responsive, due to defect in synthesis of 293 adenosylcobalamin, cbib complementation type 294 Methylmalonic -CoA epimerase deficiency 295 Mevalonic aciduria 296 Micropthalmia isolated MKS1-Realted disorders 298 Mucolipidosis III alpha/beta, atypical 299 Mucolipidosis II and III, alpha/beta 300 Mucolipidosis III gamma 301 Mucolipidosis IV Safembryo 6/9
7 302 Mucopolysaccharidosis type IIIA(Sanfilippo A) 303 Mucopolysaccharidosis type I ( including Hurler Syndrome) 304 Mucopolysaccharidosis type II 305 Mucopolysaccharidosis type II/Hunter Syndrome- X-linked 306 Mucopolysaccharidosis, MPS-III-B (Sanfilippo B) 307 Mucopolysaccharidosis type III-C 308 Mucopolysaccharidosis type III-D 309 Mucopolysaccharidosis type VI(Maroteauc-Lamy) 310 Muscle eye brain disease 311 Muscular dystrophy-dystroglycanopathy(congenital with brain and eye anomalies) 312 Muscular dystrophy-dystroglycanopathy(congenital with brain and eye anomalies) type A,1 313 Muscular dystrophy-dystroglycanopathy(congenital with brain and eye anomalies) type A,2 314 Muscular dystrophy-dystroglycanopathy(congenital with brain and eye anomalies) type A,3 315 Muscular dystrophy-dystroglycanopathy(congenital with brain and eye anomalies) type A,5 316 Muscular dystrophy, limb-girdle, type 2A 317 Muscular dystrophy, limb-girdle, type 2D 318 Muscular dystrophy, limb-girdle, type 2E 319 MUT-Related Methylmalonic acidemia 320 MYO7A-Related Disorders 321 Myopathy due to myoadenylate deaminase deficiency 322 Myotubular myopathy X-linked 323 Myotonia congenita,dominant;recessive 324 NEB-Related Nemaline myopathy 325 Nemaline myopathy 2, autosomal recessive 326 Nephrotic syndrome, type Neutropenia, severe congenital 3, autosomal recessive 328 Niemann-Pick disease type C1 329 Niemann-Pick disease type C2 330 Niemann-Pick disease, type A 331 Niemann-Pick Disease, type B 332 Niemann-Pick Disease, SMPD1-Associated 333 Nijmegen Breakage Syndrome( Ataxia telangectasia type 1) 334 Norrie Disease 335 Northen Epilepsy 336 Nystagmus 6, congenital, X-linked 337 Ornithine transcarbamylase deficiency 338 Osteogenesis imperfecta, type VIII 339 OTC deficiency/ Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome 340 PCCA-Related Propionic Acidemia 341 PCCB-Related Propionic Acidemia 342 PCDH15-Related disorders( including Usher Syndrome, Type 1F) 343 Pelizaeus-Merzbacher disease 344 Pendred's syndrome 345 Peroxisomal acyl-coa oxidase deficiency 346 Peroxisome biogenesis disorder 1A (Zellweger) 347 Peroxisome biogenesis disorder Peroxisome biogenesis disorder Peroxisome biogenesis disorder Peroxisome biogenesis disorder Peroxisome biogenesis disorder 6A (Zellweger) 352 Peroxisome biogenesis disorder 9B;Rhizomelic chondroplasia punctata, type I Safembryo 7/9
8 353 PEX1-Related Zellweger syndrome spectrum 354 Phenylalanine Hydroxylase deficiency 355 Phenylketonuria 356 PKHD1-Related Autosomal recessive polycystic kidney disease 357 Polyglandular autoimmune syndrome, type PPT1-Realted Neuronal ceroid lipofuscinosis 359 Primary carnitine deficiency 360 Primary hyperoxaluria, type I 361 Primary hyperoxaluria, type Primary hyperoxaluria, type PROP1-Related combined pituitary hormone deficiency 364 Propionic acidemia 365 Pycnodysostosis 366 Pyruvate carboxylase deficiency 367 Pyruvate dehydrogenase E1-alpha deficiency: X-linked 368 Pyruvate dehydrogenase E1-beta deficiency 369 Renpenning syndrome 370 Retinitis pigmentosa Retinitis pigmentosa Retinitis pigmentosa Retinitis pigmentosa Retinitis pigmentosa Retinitis pigmentosa Retinitis pigmentosa Retinitis pigmentosa Retinitis pigmentosa Retinoschisis, X-linked 380 Rhizomelic chondrodysplasia punctata type Rhizomelic chondrodysplasia punctata type RTEL1-Related disorders 383 Salla disease 384 Sandhoff disease, infantile,juvenile, and adult forms 385 SCID, autosomal recessive, T-negative/B-positive type 386 Segawa syndrome, autosomal recessive 387 Segawa syndrome, recessive (tyrosine hydroxylase deficiency) 388 Severe combined immunodeficiency due to ADA deficiency 389 Severe combined immunodeficiency, X-;linked 390 Short chain Acyl-CoA deyhdrogenase deficiency 391 Sjogren-Larsson syndrome 392 Smith-Lemli-Opitz syndrome 393 Spastic ataxia Charlevoix-Saguenay type 394 Spastic paraplegia 11, autosomal recessive 395 Spastic paraplegia 7, autosomal recessive 396 Spastic paraplegia 15, autosomal recessive 397 Spinal muscle atrophy (several types) 398 Spinal muscular atrophy 399 Spondylothoracic dysostosis 400 Steroid-Resistant nephrotic syndrome 401 Sulfate transporter-related osteochondrodysplasia 402 Tay-Sachs disease; GM2-gangliosidosis, several forms 403 TGM1-Related autosomal recessive congenital icthyosis Safembryo 8/9
9 404 Thalassemias, alpha- 405 Thalassemias, beta- 406 Thrombocytopenia, congenital amegakaryocytic 407 Thyroid dyshormonogenesis Thyroid dyshormonogenesis Thyroid dyshormonogenesis 2A 410 Thyroid dyshormonogenesis Thyroid dyshormonogenesis Thyroid dyshormonogenesis Thyroid hormone resistance 414 Treacher Collins syndrome Trifunctional protein deficiency 416 TPP1-Related neuronal ceroid lipofuscinosis 417 Tyrosinemia type I 418 Tyrosinemia type II 419 Usher syndrome, type 1B; Deafness, autosomal dominant Usher syndrome, type 1G 421 Usher syndrome, type 2D/Deafness, autosomal recessive Usher syndrome, type 3A 423 USH1C-Related disorders 424 USH2A-Related disorders 425 Ventricular tachycardia,catecholaminergic polymorphic, Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness 427 Very long chain acyl-coa dehydrogenase deficiency 428 VLCAD deficiency Walker-Warburg syndrome, Muscular dystrophy-dystroglycanopathy(congenital with brain and eye 429 anomalies), type A,4 430 Wilson disease 431 Wolman disease (lysosomal acid lipase deficiency) 432 Zellweger syndrome 433 Xeroderma pigmentosum, Group A 434 Xeroderma pigmentosum, Group C 435 X-linkedmental retardation (XLMR) associated with macrocephaly Safembryo 9/9
All diseases on Foresight
All diseases on Foresight Disease 11-Beta-Hydroxylase- Deficient Congenital Adrenal Hyperplasia 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 3-Hydroxy-3-Methylglutaryl- CoA Lyase Deficiency
More informationBROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING.
BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING. The Inheritest SM Carrier Screen provides relevant genetic screening for many inherited diseases found throughout the pan-ethnic US population.
More informationCHRONIC MYELOGENOUS LEUKEMIA
CHRONIC MYELOGENOUS LEUKEMIA SHUFFLING THE GENETIC DECK IN CML 9 9 (q+) 22 Ph (22q-) bcr bcr-abl abl Fusion protein causes cancer GLEEVEC AND BCR-ABL FUSION PROTEIN GENETIC MEDICINE A. Genetic diseases
More informationForesight Carrier Screen
4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: Date Received: 02/19/2018 Date Tested: 02/26/2018 Accession ID: CSL3P6DMJ324JJ4
More informationForesight Carrier Screen
321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: OG-510 Saliva Date of Collection: 07/12/2017 Date Received: 07/17/2017 Date Tested: 07/17/2017 Indication:
More informationForesight Carrier Screen
321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: OG-510 Saliva Date of Collection: 06/23/2017 Date Received: 06/28/2017 Date Tested: 06/28/2017 Indication:
More informationCLINICAL AND HUMAN TESTING
CLINICAL AND HUMAN TESTING CARRIER SCREENING FOR FAMILY PLANNING Let knowledge be your guide. Identify genetic conditions before or during a pregnancy to help predict the chances of having a child with
More informationForesight Carrier Screen
4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 09/20/2017 Date Received: 09/22/2017 Date Tested: 09/27/2017 Indication:
More informationForesight Carrier Screen
321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: EDTA Blood Date of Collection: 07/12/2017 Date Received: 07/17/2017 Date Tested: 07/17/2017 Indication:
More informationForesight Carrier Screen
4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 08/17/2017 Date Received: 08/18/2017 Date Tested: 08/24/2017 Indication:
More information23andMe Reports GENETIC HEALTH RISK REPORTS. Increased risk for breast and ovarian cancer. function
1 23andMe Reports GENETIC HEALTH RISK REPORTS BRCA1/BRCA2 Late-Onset Alzheimer's Disease Parkinson's Disease Age-Related Macular Degeneration Alpha-1 Antitrypsin Deficiency Celiac Disease G6PD Deficiency
More informationForesight Carrier Screen
Freiburg Medical Laboratory, ME LLC Box 3068 Dubai, 00000 Phone: +971 4 396 2227 FE Sample Type: EDTA Blood Date of Collection: 04/23/2018 Date Received: 04/27/2018 Date Tested: 05/05/2018 Indication:
More informationNutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions:
NutraHacker Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d Instructions: In this report, NutraHacker examines single nucleotide polymorphisms that reveal carrier status
More informationTable S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database
Table S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database Coincide nce Expected coincidence Maximum possible comorbidity Disease1 Disease2 Link(KEGG)
More informationCarrierMap. Genetic Counseling. Technology TABLE OF. Sample Report CONTENTS. New Offerings. Recombine Facts. Disease List
Recombine 2 CarrierMap 4 Genetic Counseling TABLE OF CONTENTS 8 12 14 Technology Sample Report New Offerings 18 Recombine Facts 19 Disease List CARRIERMA ROVIDES COMLETE We help families have healthy children
More informationThe Counsyl Foresight Carrier Screen
The Counsyl Foresight Carrier Screen 180 Kimball Way South San Francisco, CA 94080 www.counsyl.com contact@counsyl.com (888) COUNSYL The Counsyl Foresight Carrier Screen - Disease Reference Book 11-beta-hydroxylase-deficient
More informationFamily Prep Screen POSITIVE: HIGH REPRODUCTIVE RISK. Cystic Fibrosis
123 Main Street Houston, TX 10231 Phone: (800) 555-1212 Fax: (800) 555-1212 FE Sample Type: OG-510 Saliva Date of Collection: 07/08/2014 Date Received: 07/13/2014 Date Tested: 07/13/2014 Indication: No
More informationThe Israeli population carrier screening program. Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem
The Israeli population carrier screening program Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem The Israeli population 2015 8,134,500 inhabitants Jews (75.1%) Ashkenazi, non
More informationSperm Donor Profile. Asian American Indian African American/Black. Caucasian/White East Indian Latino/Hispanic
Sperm Donor Profile This packet is for informational purposes. All the questions have been answered by the donor and are unaltered with exception to the staff impressions, genetic screening results, and
More informationJOHN DOE JANE DOE. Reproductive Risk Summary. Counsyl Test Results Summary
Results Recipient University Medical Center 827 Attn: Dr. Paul Smith 123 Main Street Houston, TX 10231 Phone: (800) 555-1212 Fax: (800) 555-1212 NPI: 7834324983 Report Date: 09/09/2013 Female Ethnicity:
More informationA. disorders of amino acid metabolism classical phenylketonuria and hyperphenylalaninemia
OMIM # FULL NAME A. disorders of amino acid metabolism 1 261600 classical phenylketonuria and hyperphenylalaninemia 2 261640 phenylketonuria due to PTPS deficiency 3 261630 phenylketonuria due to DHPR
More informationPREDICAGEN LLC REPORT
The report below is a scientific interpretation of the DNA variants (referred as RS numbers) to the customer by a third party (for example 23andMe). The report should not be considered exclusive, because
More informationEvolve FamilyReady Carrier Screen
Evolve FamilyReady Carrier Screen Accurate & Comprehensive Expanded Carrier Screen of >200 genes for the most relevant genetic disorders for all ethnicities. Achromatopsia CNGB3 X-linked Adrenoleukodystrophy
More informationDiagnose a broad range of metabolic disorders with a single test, Global MAPS
PEDIATRIC Assessing or diagnosing a metabolic disorder commonly requires several tests. Global Metabolomic Assisted Pathway Screen, commonly known as Global MAPS, is a unifying test for analyzing hundreds
More informationFurther expansion of the neonatal screening panel in the Netherlands
Further expansion of the neonatal screening panel in the Netherlands J.Gerard Loeber APHL-NBSGT, St.Louis (MO), USA 290216 Population Area Newborns 6.01 million 0.35:1 16.8 million 180,693 sq km 4.3:1
More informationMetabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen
Metabolic Disorders ed Overseas but not ed in Australia Biotinidase Deficiency Severe form causes seizures & delay Biotin can prevent complications NZ, USA Tyrosinaemia Type I Coma & death before age 10
More informationרשימת המחלות הנסקרות בבדיקה
רשימת המחלות הנסקרות בבדיקה By סקר גנטי טרום הריון - FamilyFirst בדיקת סקר גנטי טרום הריוני מורחב, הסוקרת כ- 850 מוטציות העלולות לחולל 255 מחלות תורשתיות. הבדיקה כוללת את כל המחלות המומלצות ע"י משרד הבריאות
More informationA Lawyer s Perspective on Genetic Screening Performed by Cryobanks
A Lawyer s Perspective on Genetic Screening Performed by Cryobanks As a lawyer practicing in the area of sperm bank litigation, I have, unfortunately, represented too many couples that conceived a child
More informationResidual risks by ethnicity
Residual risks by ethnicity This table displays residual risks after a negative result for each of the genes and corresponding disorders. If a patient is reported to be a carrier of a disease, their residual
More informationWhen users open the application interface, the starting page presents a disclaimer. Upon agreeing to the
Walkthrough of IEMbase When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the disclaimer, users are directed to the main page, which presents a search
More informationSummary of Results CARRIER STATUS DNA INSIGHT. Result: Carrier, Heterozygote. Protected Health Information. Propionic Acidemia
Test Results Reviewed & Approved by: Laboratory Director, Nilesh Dharajiya,.D. SAPLE REPORT CARRIER STATUS DNA INSIGHT PERSONAL DETAILS DOB Jan 1, 19XX ETHNICITY Asian ORDERING HEALTHCARE PROFESSIONAL
More informationSAMPLE. Carrier Screening Results Report v2.2 Page 1/8
MM480: Pan-Ethnic Carrier Screen - Targeted Mutation Panel Report Prepared For: Patient: Name: Date of Birth: IDs (Internal / External): Reported Gender: Reported Ethnicity: Sample: Sample Collection Date:
More information[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995
RULES AND REGULATIONS PERTAINING TO THE NEWBORN METABOLIC, ENDOCRINE, AND HEMOGLOBINOPATHY SCREENING PROGRAM AND THE NEWBORN HEARING LOSS SCREENING PROGRAM [R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE
More informationCARRIER SCREENING PANEL
1 / 6 1. WHAT IS THE CARRIER? The carrier screening panel is a genetic test that simultaneously analyses mutations in 298 genes which cause recessive inherited pathologies. Diseases with a recessive inheritance
More informationNewborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis)
Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis) 1) Argininosuccinic acidemia (ASA) a) Incidence: ~1 in 70,000 b) Deficiency in an enzyme of
More informationRoutine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015
Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015 Metabolic birth defects can cause physical problems, mental retardation and, in some cases, death. It is
More informationResults Recipient Ordering Healthcare Professional Male Details Female Details
Results Recipient Ordering Healthcare Professional Male Details Details Report Date /2010 Attn: Jessica Jacobson, MD Counsyl, Inc. 2200 Bridge Parkway, Suite 103 Redwood City, CA 94065 Phone: 1-888-COUNSYL
More informationOur partners worldwide. CENTOGENE Report: Diagnosed cases of rare diseases at CENTOGENE. January 2012 to June 2016.
CENTOGENE Report: cases of rare diseases at CENTOGENE January 202 to June 206 Elucidating the basis for the link between the clinical phenotype and genotype correlation, and the factors contributing to
More informationHigh Impact Treatment Benefits X-Linked Moderate Impact. Disease Gene # Mutations Disease Group(s)
CarrierMap Expanded v3 Panel: 314 Diseases CarrierMap screen for 316 diseases including DMD. Disease Groups High Impact Treatment Benefits X-Linked Moderate Impact These diseases have a significant impact
More informationNEWBORN SCREENING. health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES
NEWBORN SCREENING health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES Table of Contents NEWBORN SCREENING...1 FREQUENTLY ASKED QUESTIONS...2 DISORDERS INCLUDED IN NEWBORN SCREENING...4
More informationMISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES
NEWBORN SCREENING Protecting your newborn MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES [ 1 ] NEWBORN SCREENING [ 2 ] FREQUENTLY ASKED QUESTIONS [ 4 ] DISORDERS INCLUDED IN NEWBORN SCREENING [ 12 ]
More informationNewborn Screening: Focus on Treatment
Newborn Screening: Focus on Treatment Alan R. Fleischman, M.D. Senior Vice President and Medical Director March of Dimes National Conference of State Legislatures July 21, 2008 Newborn Screening: A Public
More informationMost common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.
Newborn Screening Examination parameters: TSH-neonatal (hypothyreosis), 17-OH progesterone (AGS), galactose (galactosemia), galactose-uridyl transferase (galacto semia), biotinidase (biotinidase ), phenylalanine
More informationFor Your Baby s Health Department of Health
Newborn Screening For Your Baby s Health Department of Health Why is my baby tested? To help make sure your baby will be as healthy as possible. The blood test provides important information about your
More informationFRAMBU. Resource Centre for Rare Disorders
FRAMBU Resource Centre for Rare Disorders Frambu Resource Centre for Rare Disorders is one of nine centres working with rare disorders in Norway. All nine centres are part of the Norwegian National Advisory
More informationOverview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy
Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy Alan R. Fleischman, M.D. Senior Vice President and Medical Director Chair, Federal Advisory Committee,
More informationNEWBORN SCREENING. in Massachusetts: Answers for You and Your Baby. University of Massachusetts Medical School
University of Massachusetts Medical School NEWBORN SCREENING in Massachusetts: Answers for You and Your Baby New England Newborn Screening Program Biotech 4, 2nd Floor UMass Medical School 377 Plantation
More information23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert
Table of contents Intended Use Important warnings and limitations Test performance User studies Specific test information 23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert For in-vitro
More informationPositive Newborn Screens: What do you do next?
Positive Newborn Screens: What do you do next? James B. Gibson, MD, Ph.D. Biochemical Geneticist at Specially for Children Clinical Associate Professor of Pediatrics UTHSCSA Carla R. Scott, MD Pediatric
More informationNEWBORN SCREENING. in Massachusetts: Information for You and Your Baby. University of Massachusetts Medical School
University of Massachusetts Medical School NEWBORN SCREENING in Massachusetts: Information for You and Your Baby New England Newborn Screening Program Biotech 4, 2nd Floor UMass Medical School 377 Plantation
More information(f) "Birthing center" means any facility that is licensed by the Georgia Department of Community Health as a birthing center;
Ga. Comp. R. & Regs. r. 511-5-5-.02 Definitions Rule 511-5-5-.02. Definitions (a) "Abnormal test result" is a test result from blood testing or physiologic monitoring that is outside the screening limits
More informationPATIENT EDUCATION. carrier screening INFORMATION
PATIENT EDUCATION carrier screening INFORMATION carrier screening AT A GLANCE Why is carrier screening recommended? Carrier screening is one of many tests that can help provide information to you and your
More informationExpanded carrier screening for monogenic disorders: where are we now?
DOI: 10.1002/pd.5109 SPECIAL TOPIC ISSUE ON ADVANCES IN THE DIAGNOSIS OF SINGLE GENE DISORDERS Expanded carrier screening for monogenic disorders: where are we now? Davit Chokoshvili*, Danya Vears and
More informationCOMMON INHERITED METABOLIC CONDITIONS IN SOUTH AFRICA DIAGNOSING RARE DISEASE IN GENETICALLY UNIQUE AND UNDERSTUDIED POPULATION GROUPS
COMMON INHERITED METABOLIC CONDITIONS IN SOUTH AFRICA DIAGNOSING RARE DISEASE IN GENETICALLY UNIQUE AND UNDERSTUDIED POPULATION GROUPS S MELDAU, G VAN DER WATT INHERITED METABOLIC DISEASES GROUP UCT /
More informationStandard Therapies - Cord Blood
A healthy future is in your hands 01 02 03 04 Standard Therapies - Cord Blood Clinical Trials with Blood - Forming Stem Cells Gene Therapy for Inherited Disorders Using Blood - Forming Stem Cells Clinical
More informationpanel tests assessing multiple genes at the same time for the diagnosis of one or more related disorders
NGS tests panel tests assessing multiple genes at the same time for the diagnosis of one or more related disorders UKGTN website lists 13 laboratories offering a total of 56 panel test UKGTN listed panel
More informationQUESTION. Personal Behavior History. Donor Genetic History. Donor Medical History. Family Medical History PERSONAL BEHAVIOR HISTORY. Never N/A.
Donor 4576 Medical Profile S Personal Behavior History Donor Genetic History Donor Medical History Family Medical History PERSONAL BEHAVIOR HISTORY Current alcohol use: If yes, oz./week and type of alcohol:
More informationFABRY DISEASE 12/30/2012. Ataxia-Telangiectasia. Ophthalmologic Signs of Genetic Neurological Disease
Ophthalmologic Signs of Genetic Neurological Disease ES ROACH,MD. Ophthalmologic Signs of Genetic Neurological Disease Conjunctival lesions Corneal lesions Lesions of iris & lens Retinal vascular lesions
More informationKnowledge is power. Plan ahead with GeneAware.
MATERNAL FETAL Many patients may have questions regarding specific genetic disorders that may arise when planning or expecting a baby. That s why Baylor Genetics developed GeneAware, a reproductive carrier
More informationCoagulation factor VII deficiency. Hemophilia A (German Shepherd Dog, type 1) Pyruvate kinase deficiency (Labrador Retriever type)
Blood and Clotting Coagulation factor VII deficiency Elliptocytosis Hemophilia A (German Shepherd Dog, type 2) Pyruvate kinase deficiency (Labrador Retriever type) Thrombopathia (American Eskimo Dog type)
More informationUtility of Microarrays in Molecular Genetics
Utility of Microarrays in Molecular Genetics Madhuri Hegde, Ph.D., FACMG Associate Professor Senior Director Department of Human Genetics Emory Genetics Laboratory Emory University School of Medicine Atlanta,
More informationResults for Trendy. Explanation of Results
Canine HealthCheck Results for Trendy Trendy's genetic health profile: Trendy's appearance profile: Trendy is not at-risk for any of the diseases tested Trendy is a Female Trendy is not a carrier for any
More informationNewborn screening for congenital metabolic diseases Optional out-of-pocket tests Information Sheet
Newborn screening for congenital metabolic diseases Optional out-of-pocket tests Information Sheet Website:www.tipn.org.tw Telephone:(02)85962050 Ext. 401-403 Service line:(02)85962065 Fax:(02)85962067
More informationNewborn Screening: Blood Spot Disorders
Newborn Screening: Blood Spot Disorders Arizona s Newborn Screening Program Program Overview Panel of Disorders Disorder Descriptions Program Components Hospitals ADHS Lab ADHS Follow-up ADHS Billing Medical
More informationBULGARIAN NATIONAL PLAN. Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD)
BULGARIAN NATIONAL PLAN FOR RARE DISEASES 2009 2013 Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD) Strategy for rare diseases in Bulgaria Project of National
More information23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert
Table of contents Intended Use Important warnings and limitations Test performance User studies Specific test information 23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert For in-vitro
More informationTitle: Assessing Recommendations Related To Timeliness of Newborn Screening
Title: Assessing Recommendations Related To Timeliness of Newborn Screening Purpose: In January 2014, the Secretary s Discretionary Advisory Committee on Heritable Diseases on Newborns and Children (Committee)
More informationResults for Dar. These tests were developled and performed by Paw Print Genetics, Spokane WA. Explanation of Results
Canine HealthCheck Results for Dar Dar's demographic profile: Call Name: Dar Registered Name: Newman's Allendar of Lost Acres Breed: Collie Sex: Male Age: 0 Owner: Registration #: DN47650805 Microchip/Tattoo:
More informationHA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up
HA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up Dr. Josephine Chong Clinical Professional Consultant Centre of Inborn Errors
More informationINBORN ERRORS OF METABOLISM (IEM) IAP UG Teaching slides
INBORN ERRORS OF METABOLISM (IEM) 1 OBJECTIVES What are IEMs? Categories When to suspect? History and clinical pointers Metabolic presentation Differential diagnosis Emergency and long term management
More informationA Guide for Prenatal Educators
A Guide for Prenatal Educators Why Teach Newborn Screening This booklet is designed to make it easy for you, a prenatal educator, to effectively inform expectant parents about newborn screening. All of
More informationArchived Reports Summary
Archived Reports Summary 1 Archived Reports Summary This summary provides information that may be helpful when viewing your archived reports. The information in this document and in your reports is intended
More informationBeyond the case for NBS in South Africa. Chris Vorster 28/05/2016
Beyond the case for NBS in South Africa Chris Vorster 28/05/2016 The case for NBS in SA Economic justification Cost Utility analysis = Cost/QALY GDP/Capita Immediate implementation (WHO) Political justification
More informationNewborn Screening in Manitoba. Information for Health Care Providers
Newborn Screening in Manitoba Information for Health Care Providers Newborn screening: a healthy start leads to a healthier life Health care professionals have provided newborn screening for phenylketonuria
More informationStrand Neuromuscular Disorders Test: Genes & Test Selection
1 Strand Neuromuscular Disorders Test: Genes & Test Selection 2 Can the Strand Neuromuscular Disorders Test Be Offered for Prenatal Diagnosis? 3 Strand Neuromuscular Disorders Test: Genes & Test Selection
More informationdisease carrier status PANEL DETAILS VERSION Risk Details JANE MILLER JOHN MILLER NEGATIVE CARRIER * NEGATIVE MILD CONDITION NEGATIVE
123 Main Street City, CA 10231 Phone: (800) 555-1212 Fax: (800) 555-1212 FE Sample Type: EDTA Blood Date of Collection: 02/06/2014 Date Received: 02/16/2014 Date Tested: 02/16/2014 Indication: Screening
More informationBeyond Mendel s Laws of Inheritance
Beyond Mendel s Laws of Inheritance 2006-2007 Extending Mendelian genetics Mendel worked with a simple system peas are genetically simple most traits are controlled by a single gene each gene has only
More informationApproach to diagnosis of metabolic diseases
Translational Science of Rare Diseases 1 (2016) 3 22 DOI 10.3233/TRD-160001 IOS Press 3 Approach to diagnosis of metabolic diseases Enid Gilbert-Barness a,b and Philip M. Farrell c,d, a Department of Pathology,
More information7 Medical Genetics. Hemoglobinopathies. Hemoglobinopathies. Protein and Gene Structure. and Biochemical Genetics
SESSION 7 Medical Genetics Hemoglobinopathies and Biochemical Genetics J a v a d F a s a J a m s h i d i U n i v e r s i t y o f M e d i c a l S c i e n c e s, N o v e m b e r 2 0 1 7 Hemoglobinopathies
More informationHERES Carrier Screening TEST
LISTADO DE ENFERMEDADES ANALIZADAS HERES Carrier Screening TEST 11-Beta-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 17-Alpha-Hydroxylase Deficiency 17-Beta-Hydroxysteroid Dehydrogenase 3 Deficiency
More informationResults for Farrah. These tests were developled and performed by Paw Print Genetics, Spokane WA. Explanation of Results
Canine HealthCheck Results for Farrah Farrah's demographic profile: Call Name: Farrah Registered Name: Amber Bear's She's All That Breed: Collie Sex: Female Age: 1 Owner: Registration #: DN44645703 Microchip/Tattoo:
More informationSurvey of prenatal testing for genetic disorders in Japan: Recent report
doi:10.1111/jog.12948 J. Obstet. Gynaecol. Res. Vol. 42, No. 4: 375 379, April 2016 Survey of prenatal testing for genetic disorders in Japan: Recent report Takahiro Nobuzane 1, Takahiro Yamada 2,KiyonoriMiura
More informationShould Universal Carrier Screening be Universal?
Should Universal Carrier Screening be Universal? Disclosures Research funding from Natera Mary E Norton MD University of California, San Francisco Antepartum and Intrapartum Management June 15, 2017 Burden
More informationGUIDE TO NEWBORN SCREENING PROGRAMME
\ GUIDE TO NEWBORN SCREENING PROGRAMME 1 MEDILAB PROFILE MEDILAB, the leading independent provider of Clinical Laboratory Diagnostic Services in Cyprus, was established in 1980 by Mr. C. Pavlides and has
More informationGeneral Approach to Genetic Testing
Protocol General Approach to Genetic Testing (20491) Medical Benefit Effective Date: 01/01/17 Next Review Date: 11/18 Preauthorization Yes Review Dates: 01/11, 01/12, 09/12, 05/13, 09/13, 09/14, 09/15,
More informationPGD: A Celebration of 20 years:
PGD: A Celebration of 20 years: What is Reality and What is Not? Roma June 30, 2010 Mark Hughes, M.D., Ph.D. Professor of Genetics, Internal Medicine, Pathology Director, Genesis Genetics Institute Director,
More informationNeurodegenerative disorders: an approach to investigation. Robert Robinson Practical Paediatric Neurology Study Days April 2018
Neurodegenerative disorders: an approach to investigation Robert Robinson Practical Paediatric Neurology Study Days April 2018 Aims An approach to investigating and diagnosing young children with progressive
More informationMetabolic Changes in ASD. Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius
Metabolic Changes in ASD Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius 12 patients 3 Autism: Ages 3/3/3.7 3 PDD: Ages 3/3/6 3 Asperger: Ages 6/7/15.1 3 Speech delay and Sensory Problems (SHL):
More informationResults for Diva. These tests were developled and performed by Paw Print Genetics, Spokane WA. Explanation of Results
Canine HealthCheck Results for Diva Diva's demographic profile: Call Name: Diva Registered Name: Rus Pekos Diva Chudo Prirody Breed: Golden Retriever Sex: Female Approx. DOB: 2016-07 Owner: Registration
More informationResults for Ceaser. Em Locus (Melanistic Mask) Explanation of Results
Results for Ceaser Ceaser's demographic profile:!"## $"%&'!&"(&) *&+,(-&)&. $"%&' /000000 1)&&.' 12##.3+ /&0' 4"#& 566)307 891' :;;?!"#$%&'''''''!"#$%&'(&$)* +, -./4567 0$1')12$345(&&)),!"# $% &'&((((
More informationGenetic Diseases. SCPA202: Basic Pathology
Genetic Diseases SCPA202: Basic Pathology Amornrat N. Jensen, Ph.D. Department of Pathobiology School of Science, Mahidol University amornrat.nar@mahidol.ac.th Genetic disease An illness caused by abnormalities
More informationClinical Approach to Diagnosis of Lysosomal Storage Diseases
Clinical Approach to Diagnosis of Lysosomal Storage Diseases M. Rohrbach, MD, PhD FMH Pädiatrie und FMH Medizinische Genetik Abteilung Stoffwechsel Universitätskinderklinik Zürich Lysosomal storage disorders
More informationEURORDIS Member Organisations - Diseases - ERN Groupings Working Document
EURORDIS Member Organisations - Diseases - ERN Groupings Working Document Diseases ERN Group - Primary ERN Group - secondary Achondroplasia Fibrodysplasia ossificans progressiva Fibrous dysplasia of bone
More informationPet Profile Number: Date of Test: 00/00/0000 Date of Certificate: 00/00/0000 Canine Pet Name: Date of Birth: Pet Type: Breed: Sex: Spayed/Neutered: Co
Pet Profile Number: Date of Test: 00/00/0000 Date of Certificate: 00/00/0000 Canine Pet Name: Date of Birth: Pet Type: Breed: Sex: Spayed/Neutered: Coat Color: Eye Color: Weight: Microchip: Microchip Type:
More informationMedical Foods for Inborn Errors of Metabolism
Medical Foods for Inborn Errors of Metabolism Policy Number: Original Effective Date: MM.02.014 02/18/2000 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST 08/23/2013 Section: Medicine Place(s)
More informationConsiderations in Choosing Screening Conditions: One (US) Approach
22 Plenary Considerations in Choosing Screening Conditions: One (US) Approach Bradford L Therrell Jr, 1,2 MS, PhD Abstract The lack of a national policy on newborn screening (NBS) in the United States
More informationInborn Errors of Metabolism (IEM)
Clinical Presentation Inborn Errors of Metabolism (IEM) Click on the following: - Clinical Pearl - link to movie clip - link to picture Investigations Blood Work Urine No Acidosis NH 4 + Metabolic Acidosis
More informationSema4 Natalis. Clinical significance of panel. Testing methods, sensitivity, and limitations
Sema4 Natalis Clinical significance of panel Sema4 has designed and validated Natalis, a supplemental newborn screening panel offered for newborns, infants, and young children. This test may be offered
More informationBabyNEXT TM EXTENDED. Geni investigati e patologie associate. Gene Disease OMIM gene Familial hyperinsulinism ABCC8-related
Geni investigati e patologie associate BabyNEXT TM EXTENDED Gene Disease OMIM gene ABCC8 Familial hyperinsulinism ABCC8-related OMIM Disease Condition 600509 256450 Metabolic disorder - ABCD1 Adrenoleukodystrophy
More information